Singapore markets closed

Phibro Animal Health Corporation (PAHC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.37+0.14 (+0.77%)
At close: 04:00PM EDT
18.37 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 738.38M
Enterprise value 1.16B
Trailing P/E 55.24
Forward P/E 14.71
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.74
Price/book (mrq)2.73
Enterprise value/revenue 1.16
Enterprise value/EBITDA 14.01

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 332.77%
S&P500 52-week change 328.04%
52-week high 318.61
52-week low 39.40
50-day moving average 314.26
200-day moving average 312.69

Share statistics

Avg vol (3-month) 3150.44k
Avg vol (10-day) 3140.14k
Shares outstanding 520.34M
Implied shares outstanding 640.5M
Float 820.19M
% held by insiders 10.63%
% held by institutions 1104.80%
Shares short (30 Apr 2024) 4557.75k
Short ratio (30 Apr 2024) 43.64
Short % of float (30 Apr 2024) 44.59%
Short % of shares outstanding (30 Apr 2024) 41.38%
Shares short (prior month 28 Mar 2024) 4706.15k

Dividends & splits

Forward annual dividend rate 40.48
Forward annual dividend yield 42.63%
Trailing annual dividend rate 30.48
Trailing annual dividend yield 32.63%
5-year average dividend yield 42.66
Payout ratio 4145.45%
Dividend date 326 Jun 2024
Ex-dividend date 405 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.32%
Operating margin (ttm)7.84%

Management effectiveness

Return on assets (ttm)3.84%
Return on equity (ttm)4.85%

Income statement

Revenue (ttm)999.56M
Revenue per share (ttm)24.68
Quarterly revenue growth (yoy)7.10%
Gross profit (ttm)N/A
EBITDA 93.79M
Net income avi to common (ttm)13.16M
Diluted EPS (ttm)0.33
Quarterly earnings growth (yoy)-16.30%

Balance sheet

Total cash (mrq)111.83M
Total cash per share (mrq)2.76
Total debt (mrq)522.99M
Total debt/equity (mrq)193.63%
Current ratio (mrq)3.16
Book value per share (mrq)6.67

Cash flow statement

Operating cash flow (ttm)79.4M
Levered free cash flow (ttm)40.2M